紫鑫藥業(002118.SZ):控股股東及其一致行動人合計被司法凍結1.94億股
格隆匯1月17日丨紫鑫藥業(002118.SZ)公佈,公司通過中國登記結算有限責任公司系統查詢,獲悉公司控股股東敦化市康平投資有限責任公司(“康平公司”)及其一致行動人仲維光所持有的公司部分股份被司法凍結,康平公司所持1.32億股被司法凍結,佔其所持公司股份比例28.20%;仲維光所持6192.26萬股被司法凍結,佔其所持公司股份比例100%。
截至公告披露日,康平公司持有公司股份4.69億股,佔公司總股本的36.65%,其累計質押公司股份4.69億股,佔公司總股本的36.65%,佔其持有公司股份總數的100%,其累計被司法凍結公司股份1.32億股,佔其持有公司股份總數的28.20%。仲維光持有公司股份6192.26萬股,佔公司總股本的4.83%,其累計質押公司股份6192.26萬股,佔公司總股本的4.83%,佔其持有公司股份總數的100%,其累計被司法凍結公司股份6192.26萬股,佔其持有公司股份總數的100%。公司控股股東康平公司及其一致行動人仲維光合計被司法凍結1.94億股,佔公司股本15.17%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.